Nocodazole does not synchronize cells: implications for cell-cycle control and whole-culture synchronization by Cooper, Stephen et al.
Cell Tissue Res (2006) 324: 237–242
DOI 10.1007/s00441-005-0118-8
REGULAR ARTICLE
Stephen Cooper . Geetha Iyer .
Michael Tarquini . Patrick Bissett
Nocodazole does not synchronize cells: implications for cell-cycle
control and whole-culture synchronization
Received: 23 August 2005 / Accepted: 3 November 2005 / Published online: 24 January 2006
# Springer-Verlag 2006
Abstract It has been predicted that nocodazole-inhibited
cells are not synchronized because nocodazole-arrested cells
with a G2-phase amount of DNA would not have a narrow
cell-size range reflecting the cell size of some specific,
presumably G2-phase, cell-cycle age. Size measurements of
nocodazole-inhibited cells now fully confirm this prediction.
Further, release from nocodazole inhibition does not produce
cells that move through the cell cycle mimicking the passage
of normal unperturbed cells through the cell cycle. Nocoda-
zole, an archetypal whole-culture synchronization method,
can inhibit growth to produce cells with aG2-phase amount of
DNA, but such cells are not synchronized. Cells produced by
a selective (i.e., non-whole-culture) method not only have a
specificDNAcontent, but also have a narrow size distribution.
The current view of cell-cycle control that is based onmethods
that are not suitable for cell-cycle analysis must therefore be
reconsidered when results are based on whole-culture
synchronization.
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Introduction
In order to understand the passage of a cell through the cell
cycle—from birth by division of a mother cell to the next
division—it is important to know what events take place at
different times during the cell cycle. Because the mea-
surement of chemical events is difficult in single cells, a
large amount of effort has been expended on methods to
synchronize cells. A properly or well synchronized culture
is one in which the cells move as a uniform cohort through
the cell cycle and accurately reflect the events occurring to
a growing unperturbed cell during passage through the cell
cycle. The sine qua non of synchronization is that the cells
move uniformly through the cell cycle and divide
synchronously over a relatively narrow span of time
(Cooper 2004a; Cooper and Shedden 2003).
At the outset, it is extremely important to distinguish
between cells that are “aligned” for a particular property
but not synchronized, and those cells that are truly syn-
chronized. This distinction has sometimes been obscured
by discussion of the cell in terms of two cycles, the
“chromatin cycle” (the replication of DNA and the
associated pattern within the cell cycle) and the “growth
cycle” (the pattern of growth of cell mass and related
cellular elements). Others have observed (Gong et al. 1995)
that the cells that are “chemically” treated exhibit growth
imbalance and higher heterogeneity with respect to all
parameters measured, including the expression of cyclins
and the degree of pRB phosphorylation. What is lacking in
previous discussions of synchronization methodology is
the generality of the rule that whole-culture methods cannot
synchronize cells. A whole-culture method is a method
whereby all of the cells in a culture are treated, and no cells
are discarded, so that the entire population has been
transformed into a synchronized cohort. This rule does not
imply that whole-culture methods synchronize cells poorly,
or weakly, or occasionally, but rather that such methods do
not synchronize cells at all, even though the cells may be
aligned for some particular property, such as DNA content.
The importance of this proposal, when put forward in a
constructive way (i.e., nocodazole does not synchronize
cells), is that methods that are widely used to study the cell
cycle do not yield information regarding the normal cell
cycle. Results of cyclic changes and other changes fol-
lowing whole-culture synchronization must perforce be
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artifacts of the treatment and not related to the normal
unperturbed cell cycle.
Synchronization methods can be divided into two classes:
whole-culture methods and selective methods (Cooper
1991). Whole-culture methods are those in which the
identical treatment of all cells in a culture is proposed to
lead to a group of cells that are arrested at a specific point in
the cell cycle. Release of these growth-arrested cells is
presumed to produce a synchronized culture. Selective
methods are those methods in which a subset of the original
population is selected to produce a synchronized culture, and
the remaining cells are discarded.
Theoretical analysis has led to the conclusion that
whole-culture methods cannot synchronize cells (Cooper
1998, 2003, 2004a,b; Cooper and Shedden 2003). Whereas
a whole-culture method may produce cells with some
particular common property (e.g., all cells have a uniform
DNA content), the cell-size distribution produced after
growth arrest does not reflect or mimic the cell size of cells
of some particular cell-cycle age. Specifically, the cell-size
distribution after a whole-culture synchronization method
is predicted to be as wide as that of the original culture
(Cooper 2003), whereas the cells of a truly synchronized
culture should have a narrow size distribution reflecting the
cell size of a normal cell at a particular cell age between
birth and division.
A study of lovastatin, a compound that was originally
proposed to be a general whole-culture synchronizing
agent (Keyomarsi et al. 1991), has demonstrated that
lovastatin does not synchronize cells. Time-lapse analysis
of cell division following lovastatin arrest has shown that
the cells do not divide synchronously (Cooper 2002).
Furthermore, analysis of the published data showing
synchronized S phases and arrest with a G1-phase amount
of DNA has indeed indicated that S phases are not
synchronized, and that the cells are not arrested with a G1-
phase amount of DNA (Cooper 2002).
Nocodazole is widely used as a synchronizing agent
(see, for example, Harper 2005a; Jansen-Durr et al. 1993;
Ludlow et al. 1993; Ouyang et al. 1998). Cells treated with
nocodazole are arrested at or prior to mitosis. Support for
this proposal is the widely reported observation that noco-
dazole treatment produces cells with a G2-phase amount of
DNA (Kung et al. 1990). We now describe experiments
measuring the size distribution of cells treated with noco-
dazole and the pattern of growth following release from
growth arrest by nocodazole treatment. Comparison of
DNA and size measurements of nocodazole-arrested cells
with cells produced by a selective method (membrane
elution) support the proposal that nocodazole-arrested cells
are not synchronized.
Most importantly for our general understanding of the
normal mammalian cell cycle, we argue that the results
presented here are not restricted to the cells and conditions
used in this study, but that they apply broadly and generally
to other mammalian cells and other growth systems. The
prohibition against the experimental demonstration of a
universal negative, viz., that whole-culture methods cannot
synchronize cells, does not apply in this case. This is
because the experiments presented here are strongly but-
tressed by theoretical considerations rigorously supporting
the proposal that whole-culture methods cannot synchro-
nize cells. Here, to the theoretical concept that these
methods “cannot synchronize cells”, we add experimental




Nocodazole was purchased from Acros Organics. A
nocodazole stock solution in dimelthysulfoxide (DMSO,
10 mg/ml) was prepared. Dilution of the stock solution into
medium produced the final nocodazole concentrations.
Control treatments with DMSO indicated that DMSO at the
concentrations used to introduce nocodazole to the cells did
not alter cell growth or the cell-phase distribution.
Cells
L1210 cells, a mouse leukemic line (ATCC designation
CCL219) was used for all experiments. These cells are
non-adherent and grow with a doubling time of approxi-
mately 9–10 h.
Growth media
Liebovitz’s L–15 medium (cellgro by Mediatech, Herndon,
VA 20171) was supplemented with 2 mg/ml glucose,
100 U/ml penicillin, 100 μg/ml streptomycin, and 10%
cosmic calf serum (Hyclone; a modified calf serum sub-
stituting for fetal bovine serum). Cells were incubated at
37°C in sealed flasks, as L–15 medium does not require a
CO2 atmosphere. Cells were never grown to above 200,000
cells/ml in all experiments. Under these growth conditions,
the cells were in steady-state growth and did not approach
overgrowth conditions.
DNA analysis
Cells were collected by centrifugation, washed once in
phosphate-buffered saline (PBS, pH 7.4), and suspended in
70% ethanol. After ethanol treatment in the cold for at least
20 min, the cells were collected by centrifugation, the
ethanol was aspirated off, and the cells were suspended in
PBS containing propidium iodide (50 μg/ml) and RNase A
(100 μg/ml). After at least 20 min incubation on ice, the
cells were analyzed in a Becton-Dickinson FACScan
analyzer by using Cellquest software. Further analysis of
the data was carried out with WINMdi software.
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Cell-size determinations
Cells were counted and sized by using a Coulter Z2 electronic
cell sizer and cell counter with a 70-μmorifice. The datawere
collected and analyzed with the Z2AccuComp program from
Beckman Coulter (version 3.01). Cells were counted directly
in L–15 medium. Further analyses of the size distributions
were performed by using Excel.
Membrane elution
The method has been described in detail previously (Eward
et al. 2004; Helmstetter et al. 2003; Thornton et al. 2002)
but will be briefly presented here. Cells are grown to a
concentration of less than 200,000 cells/ml to obtain
approximately 60–70 million cells (e.g., 600 ml cells at
100,000 cells/ml contains 60 million cells). The entire
experiment is carried out in a warm room. A membrane
holder is placed in a full-view incubator within the warm
room to ensure constant temperature. To start the pro-
duction of newborn cells, 50 ml warm (37°C) PBS with
10 μg/ml concanavalin A is filtered through the membrane.
Upon completion of filtration, no residual liquid remains.
Then 100 ml warm PBS is filtered through the membrane
to remove unbound concanavalin A. Cells in 300–600 ml
medium (containing 60–70 million cells) are subsequently
filtered slowly onto the membrane with gentle suction over
approximately 3–5 min. When approximately 20–30 ml
liquid remains above the membrane, the liquid is poured
off so that the cells never dry out or are exposed to air. The
membrane apparatus is then inverted and filled with fresh
medium, which is pumped through the membrane for 5–10
min, to remove non-bound cells. The cells obtained from
this initial flow of medium through the membrane (together
with the cells in the residual medium) are collectively
referred to as the “wash-off”, which is usually in the order
of 10%–20% of the input cells. Thus, over 80% of the cells
are bound to the membrane. After the wash-off is collected,
the membrane is placed over a large funnel connected by
tubing to a peristaltic pump. Fresh medium is pumped into
the membrane holder at a rate of approximately 3.0 ml/min.
The pump connected to the bottom of the funnel pumps
liquid at approximately 4.0 ml/min. This prevents any
collection of cells in the bottom of the funnel. Newborn
cells for analysis are collected for 15–20 min.
Results
Size distribution of nocodazole-inhibited cells
Nocodazole was added to exponentially growing L1210
cells at various concentrations between 1 and 0.01 μg/ml.
After 19 h, the size distributions and DNA distributions in
the arrested cells were determined. Nocodazole-arrested
cells were larger than uninhibited cells and had a wide size
distribution (Fig. 1a). The results in Fig. 1a are shown in
Fig. 1b but with the size scale adjusted to compare the size
distributions of the nocodazole-inhibited cells with expo-
nential cells. The adjustment moves the peaks of the
nocodazole-inhibited cells to coincide with the peak of the
exponential cells. The breadth of the size distribution of
the nocodazole-inhibited cells is essentially the same as the
original cells.
Size distribution of selection-synchronized cells
A comparison of the nocodazole results with the produc-
tion of newborn cells by membrane elution (a selective
method that produces newborn cells without any inhibition,
starvation, or perturbing treatments) is instructive. The
classical membrane-elution method developed for bacteria
(Helmstetter and Cummings 1963, 1964) has been adapted
for eukaryotic cells by Helmstetter and colleagues (Eward
et al. 2004; Helmstetter 1991; Helmstetter et al. 2003;
Thornton et al. 2002). This eukaryotic membrane-elution
method, as with the bacterial system, produces newborn
Fig. 1 Size distribution of nocodazole-inhibited cells compared
with exponential control cells. L1210 cells were treated with
nocodazole (1.0 μg/ml) for 19 h. The cell size distribution of the
inhibited cells was compared with untreated control cells. a Size
distributions showing initial recorded absolute sizes. b The noco-
dazole size distribution was re-plotted to fit the peaks of the size
distribution in the exponential distribution
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eukaryotic cells continuously from cells bound to the
membrane.
Figure 2 compares the absolute size distributions of
newborn, exponential, and nocodazole-inhibited cells. Of
note, the newborn cells have a size consistent with their
being a subset of the exponential cells, but the nocodazole-
inhibited cells are larger than the largest exponential cells.
DNA content of nocodazole-inhibited cells
Cells treated with nocodazole have a DNA content that is
primarily comparable with that of G2 phase (Fig. 3). Thus,
under conditions involving the arrest of cells with a G2-
phase amount of DNA, the inhibited cells do not reflect the
sizes of cells seen during the normal G2 phase of the cell
cycle (cf. Fig. 1).
Changes following release from nocodazole inhibition
When nocodazole-inhibited cells are washed to remove the
nocodazole and then suspended in normal medium, the
results are variable and highly dependent on the precise
nocodazole concentration. One common result is illustrated
in Fig. 4 in which cells produced by selective synchroniza-
tion are compared with nocodazole-treated cells with
respect to the ability of the cells to progress from having
a G2-DNA content to having a G1-phase DNA content. In
Fig. 4a (top line), the cells obtained by membrane elution
are just entering the G2 phase of the cell cycle. Each
subsequent line is the DNA content measured every hour.
The cells leave the phase with a G2-DNA content by
dividing to produce cells all having a G1-phase amount of
DNA. In contrast, Fig. 4b shows cells arrested with a G2-
phase amount of DNA after nocodazole treatment. Upon
removal of nocodazole, the cells are not able to divide to
produce cells with a G1-phase amount of DNA. Whereas
the cells obtained by membrane elution divide completely
to produce cells with a G1-phase amount of DNA, the
nocodazole-inhibited cells exhibit some division but then
appear to “freeze” and do not continue to divide to produce
cells with a G1-phase amount of DNA. Thus, the nocoda-
zole-inhibited cells seem to be damaged to such an extent
that they do not proceed normally through the cell cycle.
Fig. 2 Comparison of the absolute size variation of newborn,
exponential, and nocodazole-inhibited cells
Fig. 3 DNA content of nocodazole-inhibited cells compared with
DNA distribution of exponential cells
Fig. 4 Comparison of membrane-eluted cells and nocodazole-
inhibited cells with respect to cells leaving the phase with G2-DNA
content. a Membrane-eluted cells grown to produce cells with a G2
amount of DNA are shown at hourly intervals for comparison (time:
top to bottom. All cells with a G2 amount of DNA lose this by
division and produce cells with a G1-phase amount of DNA.
b Nocodazole-inhibited cells (top line) were washed and restored to
control medium. At hourly intervals, samples were taken, and the
DNA content determined by fluorescence-activated chromosome
flow-sorting. A fraction of the initial cells (top line) produce cells
with a G1-phase amount of DNA, but not all cells aappear able to




The results reported here indicate that, although nocoda-
zole inhibits cells to produce a cell population with a G2-
phase amount of DNA, these cells are not synchronized.
Not only is the cell-size distribution of inhibited cells not
narrowed as expected for a truly synchronized culture, but
also, upon release of cells from nocodazole, the cells do not
progress normally through the cell cycle. Thus, nocodazole
has a deleterious or damaging (see Fig. 4) effect on cells.
Over a range of concentrations, nocodazole produces
effects that are inconsistent with cell synchronization. Most
importantly, the nocodazole-inhibition experiments sup-
port the theoretical predictions that whole-culture methods
cannot synchronize cells (Cooper 1998, 2004a,b; Cooper
and Shedden 2003).
Purpose of synchronization
The purpose of synchronizing cells is to produce cells that
can be used to measure and understand events occurring
during the normal unperturbed cell cycle. A truly syn-
chronized culture is one that mimics the passage of cells
through the normal cell cycle. A newborn cell has a number
of different properties (e.g., DNA content, cell size, protein
composition, internal cellular arrangement), and as a cell
passes through the cell cycle, each of these must necessarily
change in order to produce a dividing cell at the end of the
cell cycle. At a minimum, each component of the cell must
double so that the pre-division cell has twice as much of
everything that is present in the newborn cell. At each point
during the cell cycle, a cell has a particular constellation of
properties that are on the trajectory from newborn cell to
dividing cell. A synchronized culture should, at each point
during passage through the cell cycle, have cells with the
specific properties associated with one particular cell-cycle
age during the growth of an unperturbed cell.
If we consider two properties of a growing cell, e.g., cell
size and DNA content, a newborn cell of age 0.0 has a size
of 1.0 and a DNA content of the G1-phase. Size increases
continuously during the cell cycle so that at division (age
1.0), the cell size is 2.0. DNA also increases during the cell
cycle so that dividing cells have a DNA content that
reflects the G2-phase amount of DNA. Just prior to
division, e.g., at age 0.8, a cell may have a G2-phase
amount of DNA, and the cell size should be approximately
1.8. If a synchronized culture truly reflects the normal cell
cycle, one would expect to find that cells arrested with a
G2-phase amount of DNA have a relatively narrow cell-
size distribution of about size 1.8. With biological and
statistical variation considered, the size distribution could
vary from 1.7 to 1.9, or even be as wide as 1.6 to 2.0.
Nevertheless, the size distribution would be expected to be
narrower than the size distribution in the original culture. If
the size distribution is not narrowed, such a cell-size
distribution would indicate that the cells are not arrested at
a particular cell-cycle age reflecting the normal cell size at a
point during the division cycle. Rather, such cells are
presumably arrested with only one particular property
common to all cells. In the case of nocodazole arrest, this
property is a G2-phase amount of DNA. Other properties
would be reflective of cells of all ages, as the size
distribution in this case would include cells of all different
cell-cycle sizes.
Criteria for synchronization
Several criteria have been proposed for recognizing a truly
synchronized culture (Cooper 2004a; Cooper and Shedden
2003). From the list of 11 proposed criteria, those that are
relevant to the experimental analysis are as follows:
1) If newborn cells are produced by the synchronization
method, there should be a minimal increase in cell
number for a period of time covering a significant
fraction of the interdivision time.
2) The DNA distribution of cells should be narrow in the
synchronized cells, and these distributions should then
reflect the movement of cells through the division
cycle. Thus, newborn cells should all have a G1-phase
amount of DNA. The DNA content should then move
through the S-phase content to a period of time when
cells have only a G2-phase DNA content, followed by
a return to an essentially pure G1-phase DNA content.
3) The size distribution of newly synchronized cells should
be narrower than the size distribution of the original pop-
ulation, cell size should increase as the cells move through
the cell cycle, and during the period of cell division, there
should be a bi-modal distribution of cell sizes.
A more general consideration of the problem of
nocodazole or whole-culture synchronization is that the
alignment of cells so that all cells have a particular property
in common (e.g. all cells have a G1-phase DNA content or
a G2-phase DNA content) does not mean that the cells are
synchronized. Synchronized divisions are the sine qua non
of synchrony.
Application of these criteria to nocodazole treatment
suggests that nocodazole-inhibited cells, according to our
experimental results, are not synchronized. The cell-size
distribution is not narrow, the cells do not move through the
division cycle with a DNA content pattern indicative of
normal cell-cycle passage, and there is no indication that
cells divide synchronously.
Published work on synchronization
following nocodazole treatment
The literature on nocodazole use is enormous. Even the
subset dealing only with the cell cycle is extremely large.
We cannot re-analyze each and every paper that states that
nocodazole synchronizes cells, but a general conclusion
can be derived from those instances in which cells have been
analyzed after release from nocodazole. The overwhelming
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result is that, after nocodazole is removed, cells do not fit the
criteria of a synchronized culture. For example, Whitfield et
al. (2002) produced cells that, following release from noco-
dazole treatment, did not have a pattern of DNA that in-
dicated the cells were synchronized. Avisar et al. (2005) used
nocodazole to “synchronize” cells, but no evidence for
synchronization was presented. Another group used noco-
dazole to aid synchronization but noted that the resulting
cells were not well synchronized (Summers et al. 2005),
supporting the results reported here. A review of the use of
nocodazole to synchronize cells has been published else-
where (Harper 2005b).
When is the use of nocodazole valid?
Although we suggest that nocodazole does not synchronize
cells, we do not wish to propose that the use of nocodazole
to study aspects of cell biology is incorrect or that it
represents bad science. Nocodazole may have its proper
uses. A perusal of the literature on nocodazole indicates
that a large number of studies with nocodazole are related
to investigating the specific effects of nocodazole on
cellular and biochemical phenomena. Thus, a study of the
way that nocodazole inhibits microtubule formation and
inhibits various cellular functions is valid. However, a
suggestion that such studies are relevant to the events in the
normal cell cycle would be invalid. The major problem is
the overinterpretation of nocodazole-inhibition results in
terms of cell-cycle studies. Our results suggest that those
experiments that have involved the use of nocodazole to
study the cell cycle through “nocodazole-induced synchro-
nization” should be removed from the canon of accepted
cell-cycle experiments.
Generalization of results to other cell lines and growth
conditions
One critique of the possible extension of the results presented
here to other cells and growth conditions might be that our
results are merely related to the particular cells and growth
conditions that we have used, viz., L1210 cells grown in L–
15 medium with cosmic calf serum (the cells and conditions
used here), do not allow nocodazole to produce a
synchronized culture. However, this argument ignores the
theoretical generalization that led to the experiments
presented here. Theory predicts the results presented here
and that these results are independent of cell type or cell line.
Rather than placing the burden of proof on the proposal that
all cell lines cannot be synchronized by whole-culture
methods, we now shift the burden of proof to those who
propose using such whole-culture methods, including noco-
dazole inhibition, as synchronization methods. We reject the
argument proposing that perhaps “just around the corner”
there exists a cell line or a cell situation that can be
synchronized by suchwhole-culturemethods. Theory predicts
(Cooper 2003) that whole-culture synchronization cannot
work, and the experiments presented here support this theory.
References
Avisar D, Segal M, Sneh B, Zilberstein A (2005) Cell-cycle-
dependent resistance to Bacillus thuringiensis Cry1C toxin in
Sf9 cells. J Cell Sci 118:3163–3171
Cooper S (1991) Bacterial growth and division. Academic Press,
San Diego
Cooper S (1998) Mammalian cells are not synchronized in G1-phase
by starvation or inhibition: considerations of the fundamental
concept of G1-phase synchronization. Cell Prolif 31:9–16
Cooper S (2002) Reappraisal of G1-phase arrest and synchroniza-
tion by lovastatin. Cell Biol Int 26:715–727
Cooper S (2003) Rethinking synchronization of mammalian cells for
cell-cycle analysis. Cell Mol Life Sci 6:1099–1106
Cooper S (2004a) Is whole-culture synchronization biology’s
“perpetual motion machine”? Trends Biotech 26:266–269
Cooper S (2004b) Whole-culture synchronization can not, and does
not, synchronize cells. Trends Biotech 22:274–276
Cooper S, Shedden K (2003) Microarray analysis of gene expression
during the cell cycle. Cell Chromosom 2:1–12
Eward KL, Van Ert MN, Thornton M, Helmstetter CE (2004) Cyclin
mRNA stability does not vary during the cell cycle. Cell Cycle
3:1057–1061
Gong J, Traganos F, Darzynkiewicz Z (1995) Growth imbalance and
altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells
synchronized in the cell cycle by inhibitors of DNA replication.
Cell Growth Differ 6:1485–1493
Harper JV (2005a) Synchronization of cell populations in G1/S and
G2/M phases of the cell cycle. Methods Mol Biol 296:157–166
Harper JV (2005b) Synchronization of cell populations in G1/S and
G2/M phases of the cell cycle. Methods Mol Biol 296:157–166
Helmstetter CE (1991) Description of a baby machine for Saccha-
romyces cerevisiae. New Biol 3:1089–1096
Helmstetter C, Cummings D (1963) Bacterial synchronization by
selection of cells at division. Proc Natl Acad Sci USA 50:767–774
Helmstetter C, Cummings D (1964) An improved method for the
selection of bacterial cells at division. Biochim Biophys Acta
82:608–610
Helmstetter CE, Thornton M, Romero A, Eward KL (2003)
Synchrony in human, mouse and bacterial cell cultures—
a comparison. Cell Cycle 2:42–45
Jansen-Durr P, Meichle A, Steiner P, Pagano M, Finke K, Botz J,
Wessbecher J, Draetta G, Eilers M (1993) Differential modu-
lation of cyclin gene expression by MYC. Proc Natl Acad Sci
USA 90:3685–3689
Keyomarsi K, Sandoval L, Band V, Pardee AB (1991) Synchroniza-
tion of tumor and normal cells from G1 to multiple cell cycles
by lovastatin. Cancer Res 51:3602–3609
Kung AL, Sherwood SW, Schimke RT (1990) Cell line-specific
differences in the control of cell cycle progression in the
absence of mitosis. Proc Natl Acad Sci USA 87:9553–9557
Ludlow JW, Glendening CL, Livingston DM, DeCaprio JA (1993)
Specific enzymatic dephosphorylation of the retinoblastoma
protein. Mol Cell Biol 13:367–372
Ouyang B, Lan Z, Meadows J, Pan H, Fukasawa K, Li W, Dai W
(1998) Human Bub1: a putative spindle checkpoint kinase
closely linked to cell proliferation. Cell Growth Differ 9:877–885
Summers MK, Bothos J, Halazonetis TD (2005) The CHFR mitotic
checkpoint protein delays cell cycle progression by excluding
cyclin B1 from the nucleus. Oncogene 24:2589–2598
Thornton M, Eward KL, Helmstetter CE (2002) Production of
minimally disturbed synchronous cultures of hematopoietic
cells. Biotechniques 32:1098–1105
Whitfield M, Sherlock G, Saldanha A, Murray JI, Ball CA,
Alexnder KE, Matese JC, Perou CM, Hurt MM, Brown PO,
Botstein D (2002) Identification of genes periodically ex-
pressed in the human cell cycle and their expression in tumors.
Mol Biol Cell 13:1977–2000
242
